PCA
IDXX icon

Personal Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Personal Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$348K Buy
853
+11
+1% +$4.27K ﹤0.01% 354
2022
Q3 		$274K Hold
842
– – ﹤0.01% 378
2022
Q2 		$295K Buy
842
+210
+33% +$85.6K ﹤0.01% 355
2022
Q1 		$346K Sell
632
-11
-2% -$5.79K ﹤0.01% 358
2021
Q4 		$423K Buy
643
+6
+0.9% +$3.77K ﹤0.01% 368
2021
Q3 		$396K Sell
637
-2
-0.3% -$1.34K ﹤0.01% 346
2021
Q2 		$404K Buy
639
+47
+8% +$26K ﹤0.01% 346
2021
Q1 		$290K Sell
592
-219
-27% -$110K ﹤0.01% 395
2020
Q4 		$405K Buy
811
+22
+3% +$9.84K ﹤0.01% 330
2020
Q3 		$310K Sell
789
-15
-2% -$5.55K ﹤0.01% 324
2020
Q2 		$265K Sell
804
-45
-5% -$13K ﹤0.01% 308
2020
Q1 		$206K Sell
849
-38
-4% -$9.92K ﹤0.01% 328
2019
Q4 		$232K Buy
887
+96
+12% +$25.3K ﹤0.01% 371
2019
Q3 		$215K Buy
791
+9
+1% +$2.5K ﹤0.01% 339
2019
Q2 		$215K Sell
782
-295
-27% -$72.7K ﹤0.01% 306
2019
Q1 		$241K Buy
+1,077
New +$222K ﹤0.01% 294

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Personal Capital Advisors's IDXX Position: Q4 2022 in Review

Personal Capital Advisors increased its Idexx Laboratories (IDXX) stake by 1.3% in Q4 2022, buying an estimated $4.27K and bringing the position to 853 shares worth $348K. The position accounts for ﹤0.01% of the portfolio, ranked #354.

Personal Capital Advisors first reported a position in IDXX in Q1 2019 and has held it in 16 quarters since. The position peaked at $423K in Q4 2021. 999 funds tracked by Wall St. Rank hold IDXX as of Q4 2022.

  • Personal Capital Advisors held 853 shares of Idexx Laboratories worth $348K as of Q4 2022.
  • Personal Capital Advisors bought 11 Idexx Laboratories shares in Q4 2022, an estimated $4.27K.
  • Idexx Laboratories made up ﹤0.01% of Personal Capital Advisors's portfolio in Q4 2022, its #354 holding.
  • Personal Capital Advisors first reported a position in Idexx Laboratories in Q1 2019 and has held it in 16 quarters since.
  • Personal Capital Advisors's Idexx Laboratories position peaked at $423K in Q4 2021.
  • 999 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2022.

Based on Personal Capital Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.